1. Home
  2. VCIG vs GBIO Comparison

VCIG vs GBIO Comparison

Compare VCIG & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCIG
  • GBIO
  • Stock Information
  • Founded
  • VCIG 2013
  • GBIO 2016
  • Country
  • VCIG Malaysia
  • GBIO United States
  • Employees
  • VCIG 58
  • GBIO N/A
  • Industry
  • VCIG Diversified Commercial Services
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • VCIG Consumer Discretionary
  • GBIO Health Care
  • Exchange
  • VCIG Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • VCIG 21.7M
  • GBIO 29.5M
  • IPO Year
  • VCIG 2023
  • GBIO 2020
  • Fundamental
  • Price
  • VCIG $0.81
  • GBIO $6.29
  • Analyst Decision
  • VCIG
  • GBIO Buy
  • Analyst Count
  • VCIG 0
  • GBIO 4
  • Target Price
  • VCIG N/A
  • GBIO $37.33
  • AVG Volume (30 Days)
  • VCIG 3.8M
  • GBIO 837.8K
  • Earning Date
  • VCIG 08-26-2025
  • GBIO 08-12-2025
  • Dividend Yield
  • VCIG N/A
  • GBIO N/A
  • EPS Growth
  • VCIG N/A
  • GBIO N/A
  • EPS
  • VCIG 54.73
  • GBIO N/A
  • Revenue
  • VCIG $27,819,290.00
  • GBIO $21,230,000.00
  • Revenue This Year
  • VCIG N/A
  • GBIO N/A
  • Revenue Next Year
  • VCIG N/A
  • GBIO N/A
  • P/E Ratio
  • VCIG $0.01
  • GBIO N/A
  • Revenue Growth
  • VCIG 36.99
  • GBIO 61.15
  • 52 Week Low
  • VCIG $0.75
  • GBIO $3.00
  • 52 Week High
  • VCIG $264.60
  • GBIO $29.40
  • Technical
  • Relative Strength Index (RSI)
  • VCIG 32.75
  • GBIO 68.02
  • Support Level
  • VCIG $0.75
  • GBIO $3.96
  • Resistance Level
  • VCIG $0.93
  • GBIO $6.95
  • Average True Range (ATR)
  • VCIG 0.10
  • GBIO 0.50
  • MACD
  • VCIG 0.05
  • GBIO 0.22
  • Stochastic Oscillator
  • VCIG 11.08
  • GBIO 77.93

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: